Sanofi Pasteur, of Swiftwater, Pa., the vaccines division of Sanofi SA, gained FDA approval for its supplemental biologics license application for Fluzone intradermal quadrivalent vaccine. The vaccine has been available in trivalent formulation for three years, containing two strains of influenza A and one strain of influenza B.